Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -9.02% | +0.84% | +14.11% |
Apr. 01 | Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | North American Morning Briefing : S&P 500 Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.11% | 21.3M | |
-3.12% | 102B | |
+1.87% | 96.29B | |
+2.13% | 22.18B | |
-15.79% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.57% | 16.36B | |
+5.01% | 13.97B | |
+32.46% | 12.17B |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- ZIOPHARM Oncology : Raymond James Downgrades ZIOPHARM Oncology to Market Perform From Outperform; Price Target is $3